Search Results - Daniel El Fassi
- Showing 1 - 11 results of 11
-
1
Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy by Amina Nardo-Marino, Katrine Bukan, Henrik Vedel Nielsen, Daniel El Fassi
Published in European Journal of Rheumatology (2019-10-01)Get full text
Article -
2
PB1998: AZACYTIDINE AND ALLOGENOUS STEM CELL TRANSPLANTATION IN LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA by Daniel El Fassi, Aia Elise Jønch, Anette Bygum, Louisa Kluijver, Mette Andersen, Klaus Bruusgaard, Kirsten Grønbæk, Janneke Langendonk, Klas Raaschou Jensen, Hans Christian Wulf, Lone Friis
Published in HemaSphere (2023-08-01)Get full text
Article -
3
The multidisciplinary approach to eosinophilia by Gunhild Nynke Thomsen, Mette Niemann Christoffersen, Hanne Merete Lindegaard, Jesper Rømhild Davidsen, Gitte Nyvang Hartmeyer, Kristian Assing, Charlotte G. Mortz, Raquel Martin-Iguacel, Michael Boe Møller, Anette Drøhse Kjeldsen, Troels Havelund, Daniel El Fassi, Daniel El Fassi, Sigurd Broesby-Olsen, Michael Maiborg, Sofie Lock Johansson, Christen Lykkegaard Andersen, Christen Lykkegaard Andersen, Christen Lykkegaard Andersen, Hanne Vestergaard, Ole Weis Bjerrum
Published in Frontiers in Oncology (2023-05-01)Get full text
Article -
4
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression by Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Christina Ellervik, Christina Ellervik, Daniel El Fassi, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen, Per thor Straten, Per thor Straten
Published in Frontiers in Immunology (2022-05-01)Get full text
Article -
5
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression by Ana Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, Anne Rahbech, Marlies J. W. Peeters, Aneta Radziwon-Balicka, Carlos Zamora, Tobias Wirenfeldt Klausen, Vibe Skov, Lasse Kjær, Christina Ellervik, Christina Ellervik, Christina Ellervik, Daniel El Fassi, Daniel El Fassi, Silvia Vidal, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen, Per thor Straten, Per thor Straten
Published in Frontiers in Immunology (2022-08-01)Get full text
Article -
6
A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias by Annelies J. van Vuren, Alaa Sharfo, Simon T. Grootendorst, Stephanie van Straaten, Arjen M. Punt, Jesper B. Petersen, Daniel El Fassi, Wouter W. van Solinge, Marije Bartels, Richard van Wijk, Andreas Glenthøj, Eduard J. van Beers
Published in HemaSphere (2021-09-01)Get full text
Article -
7
Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis by Malene Risum, Jannik Helweg-Larsen, Søren Lykke Petersen, Peter Kampmann, Ulrik Malthe Overgaard, Daniel El Fassi, Ove Juul Nielsen, Mette Brabrand, Niclas Rubek, Lars Munksgaard, Marianne Tang Severinsen, Bendt Nielsen, Jan Berg Gertsen, Åsa Gylfe, Ulla Hjort, Angeliki Vourtsi, Rasmus Krøger Hare, Maiken Cavling Arendrup
Published in Journal of Fungi (2020-11-01)Get full text
Article -
8
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial by Jacob Handlos Grauslund, Morten Orebo Holmström, Morten Orebo Holmström, Evelina Martinenaite, Evelina Martinenaite, Thomas Landkildehus Lisle, Hannah Jorinde Glöckner, Daniel El Fassi, Uffe Klausen, Uffe Klausen, Rasmus E. J. Mortensen, Nicolai Jørgensen, Lasse Kjær, Vibe Skov, Inge Marie Svane, Hans Carl Hasselbalch, Mads Hald Andersen, Mads Hald Andersen
Published in Frontiers in Immunology (2023-02-01)Get full text
Article -
9
Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis by Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Bertel Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov, Hans Carl Hasselbalch
Published in Cancer Medicine (2018-08-01)Get full text
Article -
10
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study by Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen, Mads Emil Bjørn, Christen Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Dustin Andersen Patel, Lise Mette Rahbek Gjerdrum, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Christina Ellervik, Niels Pallisgaard, Mads Thomassen, Lasse Kjær, Vibe Skov, Hans Carl Hasselbalch
Published in Haematologica (2020-01-01)Get full text
Article -
11
DAHEAN: A Danish nationwide study ensuring quality assurance through real-world data for suspected hereditary anemia patients by Andreas Glenthøj, Andreas Ørslev Rasmussen, Selma Kofoed Bendtsen, Henrik Hasle, Marianne Hoffmann, Klaus Rieneck, Morten Hanefeld Dziegiel, Lene Dissing Sjö, Henrik Frederiksen, Dennis Lund Hansen, Daniel El Fassi, Mathias Rathe, Peter-Diedrich Matthias Jensen, Anne Winther-Larsen, Christian Nielsen, Marianne Olsen, Nina Toft, Mads Okkels Birk Lorenzen, Lise Heilmann Jensen, Sif Gudbrandsdottir, Jens Helby, Maria Rossing, Richard van Wijk, Jesper Petersen
Published in Orphanet Journal of Rare Diseases (2024-07-01)Get full text
Article
